Hudson Bay Capital Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Hudson Bay Capital Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$2M	–	1247
2022 Q3	$2M	Hold	200,000	–	–	0.02%	733
2022 Q2	$1.97M	Hold	200,000	–	–	0.01%	803
2022 Q1	$1.97M	Hold	200,000	–	–	0.03%	715
2021 Q4	$1.95M	Hold	200,000	–	–	0.02%	693
2021 Q3	$1.96M	Hold	200,000	–	–	0.03%	632
2021 Q2	$1.94M	Hold	200,000	–	–	0.02%	632
2021 Q1	$1.94M	Buy	+200,000	New	+$1.94M	0.02%	572

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hudson Bay Capital Management's PKBO Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 200,000 shares — an estimated $2M sold.

Hudson Bay Capital Management first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $2M in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Hudson Bay Capital Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Hudson Bay Capital Management sold 200,000 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $2M.
Hudson Bay Capital Management first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Hudson Bay Capital Management's Peak Bio, Inc. Common Stock position peaked at $2M in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.